ClinicalTrials.gg
CompletedNCT03348865FeLiCiAUpdated Jul 29, 2019

Fertility Life Counselling Aid- FeLiCiA

An interventional study of Fertility Life Counselling Aid (FeLiCiA) in Infertility/Sterility, Psychological Distress and Psychological Stress, sponsored by Andrew Weeks MD MRCOG. Completed at 1 site in Nigeria. Open to participants aged 21 Years to 45 Years. Per ClinicalTrials.gov, last updated 2019-07-29.

Sponsored by Andrew Weeks MD MRCOG · Not applicable, Interventional, and Supportive care

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
16
Allocation
Randomized
Ages
21 Years to 45 Years
Sex
All
01

Study summary

Research Objectives:

  1. To test the FeLiCiA, a 6 week intervention developed for the management of psychological morbidities associated with infertility, using external randomised control trial methods, on patients showing positive indicators for psychological morbidity amongst patients with infertility at UCH Ibadan, Nigeria.
  2. To explore and understand patient perspectives on the benefits of the FeLiCiA counselling in addition to usual clinical care.

Summary of Research:

Population:

Sample size N=42 Men \& Women (aged 21-45) with GHQ 12 score indicative of mild to moderate psychological morbidities (3 or more) among patients attending University College Hospital for infertility treatment.

Intervention:

FELICIA [N= 21 intervention] 6 weekly counselling Follow up at 6/52 and 6/12. Inclusion Criteria: Age 21-45; Exclusion Criteria: Previously diagnosed mental illness; severe anxiety \& depression or suicide intent (immediate referral); Age\<21/>45.

Comparison: [N=21 control group] Treatment as usual

Outcome:

Primary-GHQ12 score less than 3 Secondary-

  1. Sustained GHQ12 score less than 3
  2. Patient perspectives on benefits and effectiveness of intervention, and patient empowerment post intervention.
Read the detailed description

Eligible participants will be recruited by randomisation into a pilot trial of the intervention. The pilot trial will be in two groups- the intervention group (FELICIA) and the control group (No intervention/ treatment as usual). The intervention group will be see undergo a 6 weekly counselling sessions, using the FELICIA manual to deliver infertility counselling. The counselling sessions are to be delivered by the nurses at the infertility clinic who will be trained by the researcher to deliver this intervention. The FeLiCiA manual was developed by Dr Abiola Aiyenigba who is the principal investigator. FeLiCiA is based on the THINKING HEALTH PROGRAMME developed by Prof Atif Rahman, who will also be supervising the research. Further details are available in the FeLiCiA manual, which is attached to his proposal for further reference.

Semi structure interviews: Qualitative research will be carried out using one to one interviews. Patient will be asked to discuss their views regarding the benefits of the intervention in helping them manage the stresses that they face dealing with infertility.

Study Site:

The study will be carried in the University College Hospital, Ibadan, Nigeria Study Population The study population will consist of patients attending clinics for the treatment of infertility at the University College Hospital, Ibadan, Nigeria

Sampling Method (N=42):

For the external pilot RCT for testing the FeLiCiA intervention, thirty-eight patients are required to have an 80% chance of detecting, as significant at 5% level, an increase in the primary outcome measure from 5% in the control group to 40% in the experimental group. We increase this sample size by 10% to account for drop out during the 6 weeks, making up a total of 42 patients to be recruited for the trial.

Randomization:

The participants who have consented to participate in the research will be randomized into 2 groups - the Intervention group and the Control Group. The randomization is blinded and allocated using sealed opaque envelopes. The envelopes have been prepared by an independent person; all those carrying out the research have no idea what the contents of the envelopes indicate.

Patients who are eligible and wish to continue with the research will be handed a brown sealed envelope, opened for the first time in the presence of the participant. Depending on the content of the envelope patients will be randomized into either the intervention or control group.

The intervention group will receive the FeLiCiA counselling intervention while the Control group will receive treatment as usual. Counselling sessions will take place via discussion once every week for six weeks. Each counselling session will last no more than 1 hour. Interviews will also take place at the 2 follow up periods at the end of the sis weeks counselling and six months post counselling. (See follow up procedure).

Semi structure interviews:

Participants recruited for the qualitative study (one to one interviews) will be interviewed on one occasion for one to one qualitative research. An interview sessions is expected to last no more than 1 hour.

02

Conditions studied

  • Infertility/Sterility
  • Psychological Distress
  • Psychological Stress
  • Anxiety Disorders
  • Depressive Disorder

Keywords

  • Cognitive Behavioural Therapy
03

In context

Infertility

2,087 studies on the registry are indexed under Infertility; 355 are open to participants now.

This study's enrollment of 16 is below the median of 134 across 1,413 interventional studies indexed under Infertility.

Browse Infertility studies →

Lead sponsor

Andrew Weeks MD MRCOG is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. All consenting Patients aged between 21 and 45 years attending the infertility outpatient clinics, the Assisted Reproduction clinics and other gynecological, andrology and nephrology clinics for infertility treatment
  2. Patients who have been undergoing infertility treatments for over 2 years.
  3. Patients who also have a GHQ 12 score of 3 or more.
  4. Patients who have been identified having mild to moderate anxiety and/or depression using the psychometric measuring tools that would not qualify to be treated bio-medically.

Exclusion criteria

Exclusion Criteria:

  1. Non-consenting patients aged between 21 and 45 years attending the infertility outpatient clinics, the Assisted Reproduction clinics and other gynecological, andrology and nephrology clinics for infertility treatment.
  2. Participants with infertility for less than two years.
  3. Participants identified as having severe forms of anxiety and depression that require urgent psychiatric treatments/referral.
  4. Patients who have previously been clinically diagnosed and treated for with a mental illness.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Single (Outcomes assessor)
Enrollment
16 participants (actual)

Study arms

  • Experimental
    Fertility Life Counselling Aid (FeLiCiA)

    Patients to undergo weekly Felicia counselling interventions for 6 weeks; making a total of 6 sessions. Each session is expected lasts 30 mins to 1 hour.

    Behavioral: Fertility Life Counselling Aid (FeLiCiA)

  • No intervention
    Control

    Patients are to undergo treatment as usual.

Interventions

  • BehavioralFertility Life Counselling Aid (FeLiCiA)

    The FeLiCiA study is a pilot randomised control trial study of an intervention that uses cognitive behavioral therapy (CBT) method to provide counselling for infertility patients within low resource settings. this intervention is designed for management of the psychological problems associated with having infertility. It is based on the Thinking Healthy Programme by WHO.

06

What researchers measure

Primary outcomes

  1. Measurement for absence of psychological morbidities post intervention

    GHQ 12 score= less than 3 - No psychological morbidities

    Time frame: 6 weeks

Secondary outcomes

  1. Explore patient perspective on benefits of intervention using qualitative methods, post intervention.

    One to one semi structured interviews to gain patient perspectives on 1. benefits of intervention, and 2. Patient feelings of empowerment post intervention

    Time frame: 6 weeks

  2. Measurement for sustained absence of psychological morbidities, 6months post intervention

    GHQ 12 score= less than 3 - No psychological morbidities

    Time frame: 6 months

07

Study locations

1 site
  • University College Hospital, Ibadan
    Ibadan, Oyo, Nigeria
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2017 to primary completion in Mar 2018, 4 months.

Of 386 non-industry interventional studies with no phase under Infertility, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's 4 months is below that.

Counting every sponsor, half of 417 studies reached it within 24 months; a quarter within 10 and three quarters within 43.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 16, 2017
First posted
Nov 21, 2017
StartActual
Nov 20, 2017
Primary completionActual
Mar 27, 2018
CompletionActual
Jun 30, 2018
Last update
Jul 29, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 29, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03348865
Lead sponsor
Andrew Weeks MD MRCOG
Collaborators
University of Liverpool, University College Hospital, Ibadan, Nigeria
Responsible party
Andrew Weeks MD MRCOG (Professor of International Maternal Health, University of Liverpool) — Sponsor-investigator
First posted
Nov 21, 2017
Start date
Nov 20, 2017
Primary completion
Mar 27, 2018
Completion
Jun 30, 2018
Last update
Jul 29, 2019

Study contacts

Abiola O Aiyenigba, PhD Student
principal investigator · University of Liverpool

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion